OMER Stock Analysis: Buy, Sell, or Hold?
OMER - Omeros Corporation
$12.28
0.44 (3.72%)
▲
5d:
+8.29%
30d:
+32.33%
90d:
-18.46%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 13, 2026
9d
Smart Money Distribution
None View Scanner →
Strength: 7.7/10
Get Alerted When OMER Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: OMER is 12.4% above its trading range ($10.93). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: OMER is 12.4% above its trading range ($10.93). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$13.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$8.27
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OMER is currently trading at $12.28, which is considered extended relative to its 30-day fair value range of $9.46 to $10.93. From a valuation perspective, the stock is trading at a discount (Forward PE: 31.2) compared to its historical average (77.9). Remarkably, the market is currently pricing in an annual earnings decline of 26.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $12.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: OMER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.00 (+178.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, OMER is in a strong uptrend. The price is approaching resistance at $12.47. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: OMER has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $33.00 (+178.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.46 -
$10.93
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
Protect Your Profits
Holding OMER? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+12.4% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 178.7% below Wall St target ($33.00)
Trading Range Analysis
30-Day Trading Range
$9.46 -
$10.93
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$9.34
Resistance Level
$12.47
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.16
Wall Street Target
$33.00
(+178.7%)
Revenue Growth (YoY)
14.9%
Profit Margin
871.0%
Valuation Discount vs History
-26.3% cheaper
PE vs Historical
31.2 vs 77.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-26.3%
(market-implied from PE analysis)
1-Year Target
$10.66
(-10%)
2-Year Target
$9.59
(-19%)
3-Year Target
$8.63
(-27%)
3-Yr Target (if PE normalizes)
(PE: 31→78)
$21.58
(+82%)
📈
Valuation based on Current Earnings
Trailing PE: 10.20 | Current EPS (TTM): $1.17
Bull Case
$6.56
(-45%)
Analyst growth -50.0%, PE expands to 11.2
Base Case
$5.97
(-50%)
Market implied -50.0%, PE stable at 10.2
Bear Case
$8.11
(-32%)
Severe decline -20.0%, PE contracts to 8.7
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.2 to 77.9
Stabilization Target:
$29.60
(+150.0%)
PE Expansion Potential:
+150.0%
Share & Embed Analysis
Last updated: August 03, 2026 3:21 PM ET
Data refreshes hourly during market hours. Next update: 4:21 PM
Data refreshes hourly during market hours. Next update: 4:21 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OMER showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$123 | 59 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 54 HOLD |
|
IRON
Disc Medicine Inc. |
STRONG BUY
11 analysts |
$102 | 60 HOLD |
|
ARWR
Arrowhead Pharmaceutical… |
STRONG BUY
13 analysts |
$108 | 60 BUY |
Advanced OMER Option Strategies
Professional options setups generated by AI based on today's OMER price and gamma walls.
